Article: Inverness Medical Innovations Receives USDA Licensure of the BinaxNOW(R) Avian Influenza Virus Type a Antigen Test Kit.

Inverness Medical Innovations, Inc. (AMEX:IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, announced that it has received licensure from the United States Department of Agriculture (USDA) to manufacture, market and distribute the BinaxNOW(R) Avian Influenza Virus Type A Antigen Test Kit. Test results are available in 15 minutes compared to traditional methods, which can take days to produce results (see also Bird Flu).

Responding to a USDA-identified need for a rapid influenza test for veterinary use, Inverness sought and has now obtained USDA clearance for testing in avian species. Inverness is the only ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!